Why the study?
Survivors of congenital heart disease are at increased risk for neurodevelopmental impairments, prompting a review of risk factors and recommended neurodevelopmental care.
Highlights the increased risk of neurodevelopmental impairments in CHD survivors and emphasizes the need for serial developmental follow-up and multidisciplinary care.
PURPOSE OF REVIEW: To introduce the reader to the current understanding of the neurocognitive profile of congenital heart disease (CHD) survivors, the risk factors that may influence outcomes, and to the recommendations for cardiac neurodevelopmental care. RECENT FINDINGS: A growing body of literature has shown that survivors of CHD are at increased risk for neurodevelopmental impairments. Multiple elements influence each patient's risk, which likely begins in utero and extends to perioperative management, surgical considerations, and long-term clinical care. Additionally, sociodemographic factors may compound these risks. Serial developmental follow-up is recommended for children with critical CHD. SUMMARY: Though there are some clinical factors that increase risk, based on the high rate of developmental impairments for children with CHD, serial evaluations are recommended. Multidisciplinary and multicenter collaboration is ongoing and will facilitate moving this field forward to improve neurodevelopmental outcomes for children with CHD.
No takes yet. Share an insight, caveat, or question.
Ligsay et al. (2021) conducted a review in Congenital heart disease (CHD). Serial developmental follow-up was evaluated on Neurodevelopmental impairments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: